Who is sponsoring NCT03907293?

NCT03907293 is sponsored by University of Ulster.

What drugs are being tested in NCT03907293?

Interventions in NCT03907293: Exercise-based cardiac rehabilitation.

What condition does NCT03907293 study?

NCT03907293 studies Coronary Artery Disease, Coronary Arteriosclerosis, Myocardial Infarction, Myocardial Ischemia.

Is NCT03907293 still recruiting?

NCT03907293 is currently completed. Last updated 13 January 2021.

Last reviewed 2021-01-13 · How we verify

NCT03907293

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of a Cardiac Rehabilitation (CR) Programme on Molecular Mechanisms

Completed Last updated 13 January 2021

What this trial tests

trial testing Exercise-based cardiac rehabilitation in Coronary Artery Disease in 28 participants. Completed in 1 July 2020.

Timeline

23 February 2019

Primary endpoint
1 July 2020

1 July 2020

Quick facts

Lead sponsor	University of Ulster
Status	Completed
Study type	OBSERVATIONAL
Enrollment	28
Start date	23 February 2019
Primary completion	1 July 2020
Estimated completion	1 July 2020
Sites	2 locations across United Kingdom

Drugs / interventions tested

Exercise-based cardiac rehabilitation

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →
Coronary Arteriosclerosis — all drugs for Coronary Arteriosclerosis →
Myocardial Infarction — all drugs for Myocardial Infarction →
Myocardial Ischemia — all drugs for Myocardial Ischemia →

Sponsor

University of Ulster

Who can join

18 and older, any sex, with Coronary Artery Disease or Coronary Arteriosclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the effect of a cardiac rehabilitation (CR) programme on blood protein molecules that may improve the function of arteries in coronary artery disease (CAD) patients who have suffered a heart attack. CAD patients who have either agreed or disagreed to take part in a CR programme will be recruited. This will allow a comparison of the study measurements between a group of patients who complete a CR programme and a group of patients who do not. The other objective of this study is to perform interviews with the study participants and their significant others (i.e. spouse, family member, or a close friend) to listen to the reasons why patients agreed or disagreed to take part in a CR programme.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

"Why would you not listen? It is like being given the winning lottery numbers and deciding not to take them": semi-structured interviews with post-acute myocardial infarction patients and their significant others exploring factors that influence participation in cardiac rehabilit
Thompson G, Wilson IM, Davison GW, Crawford J, et al · · 2022 · cited 12× · PMID 33961501 · DOI 10.1080/09638288.2021.1919213

Verify or expand the search:

Other trials of Exercise-based cardiac rehabilitation

Trials testing the same drug.

NCT04511182 — Early Individualized-Exercise Based Cardiac Rehabilitation Programs in Patients With Acute Myocardial Infarction · NA · unknown
NCT04260958 — Remote Exercise SWEDEHEART Study · NA · recruiting

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other University of Ulster trials

Trials by the same sponsor.

NCT07253155 — Probiotics Use and Preventing Gastrointestinal Symptoms in People Living With Overweight and Obesity. · NA · enrolling by invitation
NCT06667505 — To Test an e-Health Educational Intervention Patients With an ICD · NA · recruiting
NCT06945003 — Study of Exercise Capacity and Physical Activity in Children With Congenital Heart Disease · NA · not yet recruiting
NCT06914804 — Stomasense: A New Route to the Proactive Detection and Management of Leaks Within Ostomy Pouches · NA · enrolling by invitation
NCT06921811 — Bioavailability From Chickpea Meals in Ileostomists? · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03907293 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Ulster
Last refreshed: 13 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03907293.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing